Artelo Biosciences Secures Notice Of Allowance In Japan For Patent Claims For The Intended Commercial Formulation Of Art27.13
ARTL•Japan notice of allowance for Art27.13 patent claims
Artelo Biosciences Inc. ARTL.O said it has secured notice of allowance in Japan for patent claims for the intended commercial formulation of Art27.13.
- Artelo Biosciences said the Art27.13 patent estate has been issued or allowed in the U.S., Japan and Europe.
Related News
Creative Medical Technology Holdings Successfully Completes Enrollment And Treatment Across Entire FDA-Cleared Adapt Trial, Including Opioid Cohort, Advancing Celz-201 / Olastrocel Toward Rmat Evaluation And Phase 3 Planning
CELZ•
Everpure Inc <P.N>: Oppenheimer Raises Target Price to $140 From $100
P•
